Followers | 187 |
Posts | 14734 |
Boards Moderated | 0 |
Alias Born | 08/26/2010 |
Friday, October 04, 2024 11:48:08 AM
Recent CUE News
- Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/29/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2024 09:00:05 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2024 09:00:03 PM
- Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/25/2024 01:00:00 PM
- Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 11/14/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:00:09 PM
- Cue Biopharma Announces Strategic Organizational Transition • GlobeNewswire Inc. • 11/14/2024 01:00:09 PM
- Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting • GlobeNewswire Inc. • 11/08/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:00:08 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/07/2024 09:07:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:00:07 PM
- Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting • GlobeNewswire Inc. • 10/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:17:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 08:05:39 PM
- Cue Biopharma Announces Pricing of $12.0 Million Public Offering • GlobeNewswire Inc. • 09/27/2024 03:26:30 AM
- Cue Biopharma Announces Proposed Public Offering • GlobeNewswire Inc. • 09/27/2024 03:10:15 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/26/2024 08:32:08 PM
- Cue Biopharma Announces Proposed Public Offering • GlobeNewswire Inc. • 09/26/2024 08:27:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/10/2024 08:00:02 PM
- Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:30:09 PM
Consumer Automotive Finance, Inc. Announces Cancellation of 200 Million Common Shares and Updates on Name and Ticker Symbol Change • CAFI • Dec 6, 2024 12:45 PM
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA • CATV • Dec 6, 2024 8:00 AM
Bantec's Howco Distributing Co. and Bantec Environmental Corp. Win Contracts • BANT • Dec 5, 2024 10:00 AM
Kona Gold Beverage, Inc. Announces Strategic Reorganization and a Bold New Direction • KGKG • Dec 5, 2024 9:33 AM
Branded Legacy, Inc. Strengthens Biotech Leadership, Focuses on Expansion, and Advances Strategic Rebranding • BLEG • Dec 5, 2024 8:30 AM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM